Infusion and injection technologies generated $14.2 billion in global sales during 2014. As discussed in LSI's new report, "Global Markets for Drug Delivery: Infusion and Injection Technologies in 2015," the market for these products-which include infusion systems, vascular access devices, and injection products- will be affected by critical regional factors that include initiatives to expand access to healthcare, limit the cost of expensive critical and long-term care, and improve convenience and comfort for patients undergoing chronic treatment for conditions such as diabetes and cancer. These factors are creating opportunities for manufacturers of innovative technologies that offer the promise of cost reductions by limiting the use of expensive resources.
Critical Issues Covered in this Report:
• Caseloads and other key infrastructure and market metrics;
• Quantitative factors including pricing, replacement rates, and product sales; and
• The competitive landscape for these devices in the U.S. and international markets.
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
